Spanish Red Biotech Pipeline

AbbVie

Telisotuzumab vedotin (ABBV-399)

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Non-Small Cell Lung Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I